首页 | 本学科首页   官方微博 | 高级检索  
检索        

大肠湿热型溃疡性结肠炎患者Toll-like2/4受体mRNA表达及溃结灵的干预作用
引用本文:常东,黄志新,樊亚巍,陶永胜,李辉,何方,张东坡.大肠湿热型溃疡性结肠炎患者Toll-like2/4受体mRNA表达及溃结灵的干预作用[J].中国中医急症,2008,17(4):462-464.
作者姓名:常东  黄志新  樊亚巍  陶永胜  李辉  何方  张东坡
作者单位:1. 武警广东边防总队医院,深圳,518029
2. 广州中医药大学脾胃研究所,广州,510407
3. 广东省深圳市中医院,深圳,518033
摘    要:目的探讨溃结灵颗粒配合柳氮磺胺吡啶(SASP)对大肠湿热型溃疡性结肠炎(UC)的作用机制。方法活动期UC(大肠湿热证)患者随机分为治疗组(溃结灵+SASP)与对照组(SASP),以RT-PCR方法检测治疗后肠黏膜组织内的TLR2/4mRNA表达的变化。结果病变组的TLR2/4 mRNA表达较正常对照组明显增强。治疗组治疗后较治疗前TLR2/4 mRNA表达明显减少;对照组治疗后较治疗前TLR2 mRNA表达有所减少,但无显著性差异,TLR4 mRNA表达明显减少。治疗组与对照组TLR2 mRNA表达治疗后差值比较有显著差异。治疗组与对照组的TLR2/4 mRNA表达治疗后差值比较亦有显著差异。结论溃结灵配合SASP治疗很可能是通过抑止TLR4、TLR2 mRNA表达,减弱了CD14和TLR2的协同作用,抑制TLR2依赖的脂蛋白信号转导,阻断TLR4蛋白,进而磷酸化激活κB的功能减弱,使损伤的内皮细胞得以修复,而达到治疗UC的作用。

关 键 词:溃疡性结肠炎  大肠湿热型  溃结灵
文章编号:1004-745X(2008)04-0462-03
修稿时间:2007年10月16

Changes of Toll-like Receptor 2/4 Gene Expression and Effects of Kuijieling Granules in the Patient of Ulcerative Colitis of Damp Heat in the Large Intestine Stagnation Type
Institution:CHANG Dong, HUANG Zhi-xin, FAN Ya-wei, et al( 1 Shenzhen Hospital of Armed Police( Shenzhen 518029; 2 Splenco- gastric Research Institute, Guangdong University of TCM (Guangzhou 510407) 3 Shenzhen Hospital of TCM ( Shenzhen 518033 )
Abstract:Objective: To study mechanism of Kuijieling Granules(KG) combined with SASP in treating ulcerative colitis(UC) . Methods: The patients of active UC (damp - heat syndrome) were randomly divided into 2 groups: KG + SASP group and SASP group. The TLR2 - 4mRNA expression in all cases were detected by RT - PCR. Results: There were obvious inereasement of the expression of TLR2- 4 mRNA in the pathological changes group. The TLR2 - 4mRNA expression were decreased by KG + SASP treatment . Conclusion: KG combined with SASP has definite effect on UC. it probably controls the gene expression of TLR2 - 4, singal conduction of BLP depend on by TLR2 and makes endothelial cells restored.
Keywords:Ulcerative colitis  Damp - heat syndrome  Kuijieling Granules
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号